ELANE and breast cancer: A dendritic cell (DC) vaccine based on α-lactalbumin (α-LA)-engineered breast cancer-derived exosomes with ICD inducers human neutrophil elastase (ELANE) and Hiltonol (TLR3 agonist) (HELA-Exos) was exerted by Huang et al. [157].